• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MAQUET CARDIOPULMONARY GMBH HLS SET ADVANCED 7.0; OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MAQUET CARDIOPULMONARY GMBH HLS SET ADVANCED 7.0; OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Model Number BE-HLS 7050#HLS SET ADVANCED 7.0
Device Problems Coagulation in Device or Device Ingredient (1096); Failure to Deliver (2338)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 12/18/2020
Event Type  malfunction  
Manufacturer Narrative
A follow up medwatch will be submitted when additional information becomes available.
 
Event Description
It was reported that an hls module clotted during use and flow was reduced.The hls set was replaced during treatment.Complaint #(b)(4).
 
Manufacturer Narrative
It was reported that during treatment clotting of ecmo oxygenator, followed by rise in internal pressure (pint) and delta p occurred , resulting in reduction of flows in used ecmo circuit.The hls set was replaced.The reported clots lead to a blockage and thus an increased delta pressure and reduced flow.According to our risk management file (hls set advanced 5.0 / hls set advanced 7.0, dms # 1468452, v26) following most possible root causes can lead to clotting: de-airing luer lock connection too loose; air remains in or enters the circuit; hemostasis; air or blood remains in luer lock access port; too low anticoagulation; too low at level, effect of heparin is too limited; protamine sulfate enters the hls set; administration of substitution of congealable substance such as plateles; (consumption) coagulopathy; thrombozytopenia.The production records of the affected hls module (dms#2941189 and 2956715 ) were reviewed on (b)(6) 2021.Following tests are performed according to the bop as a 100 % inspection: leak test after welding; pressure test heat exchanger; leak test water side; leak and flow test gas side; pressure test blood side; coating test.According to the final test results, all oxygenators passed the test as per specifications.Production related influences can be excluded.Based on these investigation results the reported failure ¿clotting¿ could be confirmed.The occurrence rate was calculated for the reported issue and it was determined that this is not a systemic issue.Therefore, no remedial action is required.The occurrence rate related to the reported issue is currently being monitored as part of maquet cardiopulmonary¿s trending program and additional investigations or corrections will be implemented in case of adverse trending.
 
Event Description
Complaint # (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HLS SET ADVANCED 7.0
Type of Device
OXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
MAQUET CARDIOPULMONARY GMBH
neue rottenburger strasse 37
hechingen
MDR Report Key11145379
MDR Text Key227110379
Report Number8010762-2021-00006
Device Sequence Number1
Product Code DTZ
Combination Product (y/n)N
PMA/PMN Number
K112360
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,foreign,health profe
Type of Report Initial,Followup
Report Date 02/24/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/11/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberBE-HLS 7050#HLS SET ADVANCED 7.0
Device Catalogue Number701047753 (HLS SET)
Device Lot Number70138118 (HLS MODULE)
Date Manufacturer Received02/17/2021
Is This a Reprocessed and Reused Single-Use Device? Yes
Patient Sequence Number1
Patient Age45 YR
-
-